CRK and carcinoma: miR-126, contrary to miR-21 and miR-221, can act as a tumour suppressor in several carcinomas such as lung, gastric, breast and PDAC through the inhibition of epidermal growth-factor-like domain 7 (EGFL7), Crk, and SLC7A5 [88].